Sunesis Pharmaceuticals, Inc. Made Big Gain
Fri, Mar 05, 2021 at 05:30 PM
Sunesis Pharmaceuticals, Inc. (SNSS:NASDAQ) jumped higher at $5.32, representing a gain of 24.3%. The stock appeared on our News Catalysts scanner on Wed 24 Feb 21 at 04:49 PM in the 'MERGER' category. From Thu 18 Feb 21, the stock recorded 20.00% Up Days and 72.73% Green Days
The stock spiked on Wed 24 Feb 21 at $7.09 with a volume of 70M+.
About Sunesis Pharmaceuticals, Inc. (SNSS:NASDAQ)
Sunesis Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers.
Top 10 Gainers:
- Second Sight Medical Products, Inc. (EYES:NASDAQ), 304.9%
- Global Partner Acquisition Corp. (GPAC:NASDAQ), 100%
- Sify Technologies Limited (SIFY:NASDAQ), 45.93%
- AMTD International Inc. (HKIB:NYSE), 36.55%
- XTL Biopharmaceuticals Ltd. (XTLB:NASDAQ), 29.76%
- Purple Innovation, Inc. (PRPL:NASDAQ), 27.94%
- Medley LLC NT 24 (MDLQ:NYSE), 26.41%
- Plus Therapeutics, Inc. (PSTV:NASDAQ), 25.56%
- TSHA (TSHA:NASDAQ), 25.47%
- Sunesis Pharmaceuticals, Inc. (SNSS:NASDAQ), 24.3%